FOLH1 and prostate cancer: PSMA aptamer‐displaying EVs were loaded with survivin siRNA and significantly inhibited prostate cancer xenograft in mice.[207] Unfortunately, this study did not investigate the in vivo biodistribution of EVs decorated with PSMA aptamers.